LeMaitre Vascular
LMAT
142 hedge funds and large institutions have $448M invested in LeMaitre Vascular in 2017 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 49 reducing their positions, and 28 closing their positions.
2.64% more ownership
Funds ownership: 70.36% → 73.01% (+2.6%)
6% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 49
4% less funds holding
Funds holding: 148 → 142 (-6)
10% less capital invested
Capital invested by funds: $501M → $448M (-$52.4M)
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $280K
Top Buyers
| 1 |
EIP
Epoch Investment Partners
New York
|
+$25.4M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$16.2M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$14.3M |
| 4 |
BIA
Biondo Investment Advisors
Milford,
Pennsylvania
|
+$3.99M |
| 5 |
BlackRock
New York
|
+$2.83M |
Top Sellers
LMAT Hedge Fund Activity: Q4 2017 in Review
142 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2017, worth a combined $448M — down 10% from $501M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of LMAT and 22 opened new positions — a net loss of 6 holders — while 49 trimmed existing stakes and 52 added.
The largest buyer was Epoch Investment Partners, opening a new position worth an estimated $25.4M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $4.66M sold.
- 142 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2017, down from 148 in Q3 2017.
- Funds reported $448M of LeMaitre Vascular stock for Q4 2017, down 10% quarter-over-quarter.
- 22 funds opened new LeMaitre Vascular positions in Q4 2017 and 28 closed out, a net change of -6 holders.
- The largest LeMaitre Vascular buyer in Q4 2017 was Epoch Investment Partners, an estimated $25.4M added.
- The largest LeMaitre Vascular seller in Q4 2017 was Bogle Investment Management, an estimated $4.66M sold.
Based on aggregated 13F filings for Q4 2017.